✨ Your Portfolio is fetched and updated from zerodha.

Astrazeneca Pharma India Ltd.

ASTRAZEN

Market Cap
₹16,952 Cr.
P/E
206.93

Astrazeneca Pharma India Ltd.

About
AstraZeneca Pharma India Limited (AZPIL) operates as a subsidiary of AstraZeneca Plc, UK, and is dedicated to providing life-changing medicines through innovative science. The company focuses on areas… Read more
AstraZeneca Pharma India Limited (AZPIL) operates as a subsidiary of AstraZeneca Plc, UK, and … Read more
Low
4785
52W Range
High
8139
  • Astrazeneca Pharma I
  • Eris Lifesciences
  • Caplin Point Lab
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
1.42 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
1.71 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.56 %
(as of May 19)
Historic
Blood Related - Market Share
1.73 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.94 %
(as of Nov 21)
Historic
Endocrinology - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Dosage Form Break-Up

Brand Wise Break-Up - Oncology

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Crestor
    Suppliers
    • Piramal Enterprises Ltd.
    • Cigniti Technologies Ltd.
    • Gulshan Polyols Ltd.
    • Take Solutions Ltd.
    • Vivimed Labs Ltd.
    FAQs on Astrazeneca Pharma India Ltd. Business

    AstraZeneca Pharma India, a subsidiary of AstraZeneca Plc, focuses on delivering innovative medicines in cardiovascular, renal, metabolic diseases, oncology, and respiratory therapies.

    Astrazeneca Pharma I major competitors are Eris Lifesciences, Caplin Point Lab, Jubilant Pharmova, Alembic Pharma, Sanofi India, Natco Pharma, Pfizer.
    Market Cap of Astrazeneca Pharma I is ₹16,952 Crs.
    While the median market cap of its peers are ₹17,211 Crs.

    Astrazeneca Pharma I seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Astrazeneca Pharma India Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material